title: Prediction of neutropenia-related effects of a new combination therapy with the anticancer drugs BI 2536 (a Plk1 inhibitor) and pemetrexed.
authors.affiliation: Department of Pharmacy and Pharmaceutical Technology, School of Pharmacy, University of Navarra, Pamplona, Spain. elena.soto@pfizer.com
authors.forename: E
authors.initials: E
authors.lastname: Soto
authors.forename: A
authors.initials: A
authors.lastname: Staab
authors.forename: M
authors.initials: M
authors.lastname: Freiwald
authors.forename: G
authors.initials: G
authors.lastname: Munzert
authors.forename: H
authors.initials: H
authors.lastname: Fritsch
authors.forename: C
authors.initials: C
authors.lastname: Döge
authors.forename: I F
authors.initials: IF
authors.lastname: Trocóniz